PRESCRIBED USE OF CHOLESTEROL-LOWERING DRUGS IN THE UNITED-STATES, 1978 THROUGH 1988

被引：66

作者：

WYSOWSKI, DK

KENNEDY, DL

GROSS, TP

机构：

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1990年 / 263卷 / 16期

关键词：

D O I：

10.1001/jama.263.16.2185

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2185 / 2188

页数：4

共 28 条

[1]

[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360

[2]

BERNSTEIN MJ, 1985, JAMA-J AM MED ASSOC, V253, P2080

[3] 15 YEAR MORTALITY IN CORONARY DRUG PROJECT PATIENTS - LONG-TERM BENEFIT WITH NIACIN [J].

CANNER, PL ;

BERGE, KG ;

WENGER, NK ;

STAMLER, J ;

FRIEDMAN, L ;

PRINEAS, RJ ;

FRIEDEWALD, W .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (06) :1245-1255

[4]

CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36

[5] CHANGES IN PHARMACOLOGIC TREATMENT OF HYPERLIPIDEMIA [J].

CROUSE, JR ;

RYU, JE ;

KAHL, FR .

AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 1989, 5 (02) :90-94

[6] HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE [J].

FRICK, MH ;

ELO, O ;

HAAPA, K ;

HEINONEN, OP ;

HEINSALMI, P ;

HELO, P ;

HUTTUNEN, JK ;

KAITANIEMI, P ;

KOSKINEN, P ;

MANNINEN, V ;

MAENPAA, H ;

MALKONEN, M ;

MANTTARI, M ;

NOROLA, S ;

PASTERNACK, A ;

PIKKARAINEN, J ;

ROMO, M ;

SJOBLOM, T ;

NIKKILA, EA .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) :1237-1245

[7]

GOTTO AM, 1984, CIRCULATION, V69, P1067

[8]

GRUNDY SM, 1988, NEW ENGL J MED, V319, P24

[9]

Health. & N.R.C.U.C.o.D.a., 1989, DIET HLTH IMPLICATIO

[10] LIPID-LOWERING DRUGS - AN OVERVIEW OF INDICATIONS AND OPTIMUM THERAPEUTIC USE [J].

ILLINGWORTH, DR .

DRUGS, 1987, 33 (03) :259-279

← 1 2 3 →